Ricevi le ultime notizie sulle azioni 9 Meters Biopharma con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di NMTRQ

Ultime notizie per

9 METERS BIOPHARMA INC by 9 Meters Biopharma, Inc.

9 Meters Biopharma Inc

9 Meters Biopharma

9 Meters Biopharma (NMTRQ) Previsione

Vendite allo scoperto

Rapporto azionario

9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.

Comments

9 Meters Biopharma Notizie sulle azioni

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO